Monday, April 11, 2022

Pfizer recorded so many adverse events that it had to hire 2,400 more employees to handle paperwork and data processing

 FULL  ARTICLE  HERE:

Carefully  Selected  Paragraphs,
by Ye Editor

" ... The latest batch of Pfizer documents, released on April 1, is made up of 11,043 pages worth of data, including an unredacted version of the company’s post-marketing experience report.

In one of the released documents, titled “Cumulative Analysis of Post-Authorization Adverse Event Reports,” written on April 30, 2021, Pfizer admitted that it was receiving so many adverse event reports regarding its ineffective vaccine that it had to hire an additional 2,400 employees to help the company with the additional data processing and paperwork requirements.

The document stated: “Pfizer has also taken multiple actions to help alleviate the large increase of adverse event reports. This includes significant technology enhancements and process and workflow solutions, as well as increasing the number of data entry and case processing colleagues.

To date, Pfizer has onboarded approximately 600 additional full-time employees. More are joining each month with an expected total of more than 1,800 additional resources by the end of June 2021.”

The data uncovered from the Pfizer and FDA documents prove two things that many health freedom advocates have already known about since the beginning. First, Pfizer’s mRNA COVID-19 vaccine is dangerous.

“The rollout of the Pfizer vaccine has led to an unprecedented number of adverse events reported – 158,000 adverse events in the first two-plus months of the rollout means that the rate of reported adverse events was approximately one for every 1,000, with many of the adverse events graded as serious,” remarked Brian Hooker, chief scientific officer of Children’s Health Defense.

 “It is no wonder that an army of individuals was needed to process all of the information.”In some of the documents, Pfizer commissioned peer-reviewed scientific articles to claim that the Big Pharma company should continue developing and evaluating its mRNA vaccine despite the appearance of serious adverse effects among many of the trial participants. " ...